Issued Patents 2022
Showing 1–10 of 10 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11529391 | Reversing deficient hedgehog signaling restores deficient skeletal regeneration | Michael T. Longaker, Ruth Tevlin, Charles K.F. Chan | 2022-12-20 |
| 11518806 | Methods for treating cancer by achieving therapeutically effective doses of anti-CD47 antibody | Stephen Willingham, Maureen Howard, Jie Liu, Ravindra Majeti, Susan Sweeney Prohaska +2 more | 2022-12-06 |
| 11472878 | Methods for determining and achieving therapeutically effective doses of anti-CD47 agents in treatment of cancer | Mark P. Chao, Ravindra Majeti, Jie Liu, Jens-Peter Volkmer | 2022-10-18 |
| 11459388 | Compositions and methods for inducing phagocytosis of MHC class I positive cells and countering anti-CD47/SIRPA resistance | Roy Louis Maute, Kipp Andrew Weiskopf, Aaron Michael Ring | 2022-10-04 |
| 11419897 | Engraftment of stem cells with a combination of an agent that targets stem cells and modulation of immunoregulatory signaling | Judith A. Shizuru, Kipp Andrew Weiskopf, Aaron Michael Ring, Akanksha Chhabra, Peter Schnorr | 2022-08-23 |
| 11377495 | Markers of acute myeloid leukemia stem cells | Ravindra Majeti, Siddhartha Jaiswal, Mark P. Chao | 2022-07-05 |
| 11369641 | Identification and uses of vasculature forming progenitor cells and progenitor cell combinations | Charles K.F. Chan, Andrew S. Lee, Michael T. Longaker, Joseph Wu, Divya Nag +1 more | 2022-06-28 |
| 11286301 | Antifibrotic activity of CD47 blockade | Gerlinde Wernig | 2022-03-29 |
| 11253588 | Combination therapy for treatment of coronary artery disease | Nicholas J. Leeper | 2022-02-22 |
| 11230607 | CD47 targeted therapies for the treatment of infectious disease | Kipp Andrew Weiskopf, Kim J. Hasenkrug, Cheryl A. Stoddart, Joseph M. McCune | 2022-01-25 |